Comparing only smoker groups, the frequencies of XRCC1, APEX1, XPD, CYP2A6*2 and CYP2A6*9 genetic polymorphisms were similar in both controls and breast cancer patients (Table 3). This evidence concerns the gene ERCC2 and breast carcinoma.